The three worst biotech stocks of 2018 so far that claim market caps of at least $500 million are Prothena Corporation (NASDAQ:PRTA), Tesaro (NASDAQ:TSRO), and Acadia Pharmaceuticals (NASDAQ:ACAD). Here's why these stocks have taken a beating so far this year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,